Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SciDevASX:SDV -3.03%50 Revenue per Share is A$0.45 as of Jun. 2026. GuruFocus rates ASX:SDV with a GF Score™ of 50/100 and a GF Value™ of A$0.28 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 1,539 Chemicals companies, SciDev ranks worse than 54.45% on this metric.
SciDev's revenue per share for the
six
months ended in Jun. 2026 was A$0.20.
SciDev's revenue per share for the trailing twelve months (TTM) ended in Jun. 2026 was A$0.45.
Warning Sign:
SciDev Ltd revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue Per Share Growth Rate of SciDev was -17.30% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was -1.70% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 13.00% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 38.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for SciDev's Revenue per Share or its related term are showing as below:
ASX:SDV'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -71.7 Med: 7.3 Max: 501.6
Current: -1.7
During the past 13 years, SciDev's highest 3-Year average Revenue Per Share Growth Rate was 501.60% per year. The lowest was -71.70% per year. And the median was 7.30% per year.
ASX:SDV's 3-Year Revenue Growth Rate is ranked worse than 54.45% of 1539
companies
in the Chemicals industry
Industry Median: -0.4
vs ASX:SDV: -1.70
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
SciDev Revenue per Share Related Terms
SciDev Revenue per Share Historical Data
* Premium members only.
The historical data trend for SciDev's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:SDV vs LIN, SHW, ECL: Revenue per Share Comparison
For the Specialty Chemicals subindustry, SciDev's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SciDev PS Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, SciDev's PS Ratio distribution charts can be found below:
* The bar in red indicates where SciDev's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
SciDev's Revenue Per Share for the fiscal year that ended in Jun. 2026 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.45
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SciDev (ASX:SDV) has a Revenue per Share of A$0.45 as of Jun. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on SciDev and its competitors. According to the industry distribution chart, SciDev ranks #838 out of 1539 companies in the Chemicals industry, placing it in the top 54.5%.
Is SciDev's Revenue per Share too high?
SciDev's current Revenue per Share is A$0.45. Based on the distribution chart, SciDev ranks #838 out of 1539 companies in the Chemicals industry, which is below the industry midpoint. Overall, SciDev has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SciDev's Revenue per Share compare to LIN and SHW?
According to the Chemicals industry distribution chart, SciDev ranks #838 out of 1539 companies for Revenue per Share. This places SciDev in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Chemicals company?
A good Revenue per Share depends on the Chemicals industry context. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on SciDev and its competitors. SciDev's current Revenue per Share is A$0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SciDev stock overvalued right now?
Based on GuruFocus' analysis, SciDev (ASX:SDV) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.28, compared to a current price of A$0.16 — trading 42.9% below its estimated fair value. The current Revenue per Share is A$0.45. SciDev's overall GF Score™ is 50/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For SciDev (ASX:SDV), the current Revenue per Share is A$0.45 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SciDev (ASX:SDV) Overvalued in 2026?
Based on GuruFocus' analysis, SciDev stock appears to be undervalued.
The current stock price of A$0.16 is trading 42.9% below its estimated GF Value™ of A$0.28.
GuruFocus considers SciDev to be Possible Value Trap.
Key valuation signals for ASX:SDV:
Revenue per Share: A$0.45
GF Value™: A$0.28 vs. price of A$0.16 (42.9% below fair value)
No single metric tells the full story. See the ASX:SDV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SciDev Ltd is an Australian environmental technology and chemical services company serving water-intensive industries. It operates through segments including Chemical Services and Water Technologies. The Chemical Services business develops, manufactures, and supplies specialty chemistries and performance solutions used in mining, oil and gas, and construction to improve operational efficiency, reduce waste, and lower water consumption. The Water Technologies segment provides treatment systems and technologies for industrial water and wastewater management, including clarification, flocculation, and solids separation. Customers are primarily industrial operators in the resources, energy, and infrastructure sectors. The company generates the majority of its revenue from the United States, with additional revenue from Australia, Asia, and other regions. Its revenue model combines ongoing chemical supply contracts with project-based technology sales and related services.
50GF Score
Get the complete analysis for ASX:SDV
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:SDV has been successfully added to your 
